Sharemaestro Newsreel

LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss

LifeMD (NASDAQ:LFMD) reported disappointing Q2 2026 results, missing both revenue and non-GAAP EPS consensus estimates. The virtual care and pharmacy services company posted revenue of $47.3 million against a $50.1 million consensus, and a non-GAAP loss per share of $0.16 compared to an expected …

LifeMD (NASDAQ: LFMD) posts Q2 $47.3M revenue, cuts 2026 guidance

LifeMD reported Q2 2026 telehealth revenue of $47.3 million, a 4% year-over-year decrease, though within guidance, as it transitions weight-management patients to branded GLP-1 therapies and longer subscriptions. The company increased active subscribers by 20% to approximately 356,000, and gross margin expanded to 89%. …

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why

Mangoceuticals (MGRX) stock surged over 49% after hours following news that its merger partner, Nuclea Energy Inc., through its subsidiary Nuclea Energy USA Inc., signed a memorandum of understanding with Utah's Office of Energy Development. This MOU explores siting a nuclear test reactor for …

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger (Nasdaq: SDGR) announced its second quarter 2026 financial results, reporting ACV of $29.6 million, a 27% increase year-over-year, and total revenue of $58.9 million, an 8% increase. The company also launched an early access version of Bunsen, its new agentic AI co-scientist for …

LifeMD earnings missed by $0.06, revenue fell short of estimates

CARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary

CARLSMED, INC. reported its Q2 2026 financial results, with revenue increasing by 56.7% year-over-year to $18.94M. Despite this growth, the company recorded a net loss of $(10.51M) and a diluted loss per share of $(0.39). Key drivers for revenue growth included increased procedure volumes …

LifeMD Q2 Results: Revenue falls 3%, adjusted EBITDA loss widens

LifeMD reported a 3% year-over-year revenue decline to $47.3 million in Q2 2026, while its adjusted EBITDA swung to a $3.5 million loss, primarily due to higher customer acquisition costs and a strategic shift to branded GLP-1 therapies. Despite the revenue dip, gross margin …

HeartBeam, Inc. (BEATW) Analyst insights, Price targets and Recommendations

The article provides analyst insights, price targets, and recommendations for HeartBeam, Inc. (BEATW). It includes current stock performance, related tickers, and general market data. The stock BEATW is shown to be trading at $0.0150, down 30.23% at market close on August 7.

Price to earnings forward of Heartbeam, Inc. – NASDAQ:BEATW

This article provides financial information for Heartbeam, Inc. (NASDAQ:BEATW), specifically focusing on its Price to Earnings (forward) metric. It is presented through TradingView, noting that the market is currently closed with no trades. The content highlights the company's financial data and general market information …

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

This article provides an earnings forecast for GoodRx Holdings Inc (GDRX), highlighting its current earnings forecast score, average price target, and analyst ratings. Based on 15 analysts, the stock has a "Hold" rating, with an average price target of $5.00. The expected revenue for …

Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results

Schrodinger (NASDAQ:SDGR) announced quarterly earnings results, significantly surpassing analyst expectations with an EPS of $0.08 against an estimated loss of $0.41, and revenue of $58.89 million, exceeding estimates of $47.19 million. The company's software annual contract value grew 27%, driven by large pharmaceutical, biotech, …

GoodRx (NASDAQ:GDRX) Posts Earnings Results, Hits Estimates

Earnings call transcript: LifeMD posts Q2 revenue miss, shares sink in after-hours

LifeMD (LFMD) reported a Q2 revenue miss of $47.3 million against an analyst forecast of $49.15 million, alongside an adjusted EBITDA loss and a lowered full-year 2026 outlook, causing shares to drop over 17% in after-hours trading. Despite the financial setbacks, the company highlighted …

BlackRock, Inc. Adds to Talkspace Inc (TALK) Stake -- Shares Loo

BlackRock, Inc. increased its stake in Talkspace Inc (TALK) by purchasing an additional 710,562 shares at $5.20 each, bringing its total holdings to over 11.1 million shares. This move reflects BlackRock's confidence in the virtual behavioral healthcare provider, despite Talkspace shares appearing approximately 26% …

Healthequity Inc stock hits 52-week high at 106.42 USD By Investing.com

Healthequity Inc (HQY) stock reached a new 52-week high of $106.42, demonstrating a 15.42% positive change over the past year and a 32.5% return in the last six months. This surge follows strong Q1 fiscal year 2027 results, surpassing market expectations for EPS and …

Certara Announces Leadership Change in Commercial Executive Role

Certara, Inc. announced that Leif E. Pedersen has departed from his role as President and Chief Commercial Officer, effective August 1, 2026. Pedersen will remain as a Senior Advisor through December 31, 2026, to facilitate the transition, and will receive severance benefits as per …

Transcript : Carlsmed, Inc., Q2 2026 Earnings Call, Aug 05, 2026

This article provides the transcript for Carlsmed, Inc.'s Q2 2026 Earnings Call held on August 5, 2026. It also includes recent news and analyst ratings concerning Carlsmed, such as Truist adjusting its price target and Needham initiating coverage. The content emphasizes that the full …

Certara, Inc. Stock 12‑Month Price Target Cut to $7.83

Analysts have reduced the average 12-month price target for Certara, Inc. (CERT) stock from $7.93 to $7.83, with individual forecasts ranging from $6 to $9 per share. Despite the cut in the price target, the consensus rating among 13 covering analysts remains a "Buy," …

LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

LifeMD, Inc. (LFMD) reported a Q2 loss of $0.16 per share, which was an earnings surprise of +20.00% compared to the Zacks Consensus Estimate of a $0.2 loss. However, the company missed revenue estimates, posting $47.28 million against an estimated $49.10 million. Despite outperforming …

Piper Sandler Keeps Their Hold Rating on Tempus AI, Inc. Class A (TEM)

Piper Sandler reiterated a Hold rating on Tempus AI, Inc. Class A (TEM) with a price target of $56.00, according to analyst David Westenberg. This follows Tempus AI's latest earnings report showing quarterly revenue of $382.49 million and a net profit of $5.64 million, …

Price to sales forward of Heartbeam, Inc. – NASDAQ:BEATW

This page from TradingView provides a financial overview for Heartbeam, Inc. (NASDAQ: BEATW), specifically focusing on its Price to Sales (forward) metric. The content lists various navigation options and product offerings by TradingView, but the core financial data regarding Heartbeam, Inc.'s price to sales …

Sean Duffy Sells 12,944 Shares of Omada Health (NASDAQ:OMDA) Stock

Is Schrodinger Inc (SDGR) Undervalued After Q2 Earnings Reveal $58.9 Million Revenue? GF Score: 73/100

LifeMD Q2 2026 slides tout AI platform, results miss targets

LifeMD presented an investor overview in August 2026, highlighting its AI-enabled virtual care platform and growth strategy, despite second-quarter results missing Wall Street expectations. The company's shares fell significantly following the earnings release, nearing its 52-week low. The presentation emphasized LifeMD's transformation into a …

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock

SOPHiA GENETICS Chairman Jurgi Camblong sold 20,000 shares of the company's stock for $138,400 under a pre-arranged Rule 10b5-1 plan, reducing his ownership by 0.57%. This insider sale comes amidst mixed quarterly results where revenue exceeded expectations but the company reported a larger-than-anticipated loss …

Tempus AI, Inc. (TEM) director sells 370 shares under 10b5-1 plan

Tempus AI, Inc. director David R. Epstein sold 370 shares of Class A Common Stock on August 3, 2026, at a price of $43.40 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2024. Following this transaction, Epstein directly holds …

Tempus AI, Inc. (TEM) CEO's spouse sells 23,818 shares in plan

The spouse of Ryan Fukushima, CEO of Data at Tempus AI, Inc. (TEM), sold 23,818 shares of Class A Common Stock on August 3, 2026. These sales were conducted under a Rule 10b5-1 trading plan at weighted-average prices between $43.25 and $46.94. Following these …

SOPHiA GENETICS SA 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SOPH) 2026-08-05

SOPHiA GENETICS SA (NASDAQ:SOPH) published its Q2 2026 earnings call presentation, reporting an EPS of -$0.20, which beat estimates by $0.02. The company also announced revenue of $23.31M, representing a 27.22% year-over-year increase and beating expectations by $1.60M. The slide deck was released in …

Schrodinger, Inc. 2026: Revenue $58.89M, EPS $0.08— 10-Q Summary

Schrodinger, Inc. reported strong financial results for the quarter ended 2026, achieving profitability with revenue of $58.89M and diluted EPS of $0.08. This marks a significant improvement from the prior-year quarter's $54.76M revenue and ($0.59) EPS. The growth was driven by drug discovery milestones …

Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC

Dimensional Fund Advisors LP significantly reduced its stake in Teladoc Health, Inc. by 16% in the first quarter, selling 1.2 million shares but still retaining over 6.3 million shares valued at approximately $34.3 million. Despite beating EPS estimates, Teladoc's revenue declined year-over-year and missed …

So-Young International names new CFO

So-Young International Inc. (SY.US) has appointed Shen Nan as its new CFO, effective August 3rd, replacing CEO Jin Xing who served as interim CFO. Shen Nan previously held the CFO position at Gaotu Techedu. The cosmetic surgery company reported a 45.8% increase in Q1 …

SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing

SOPHiA GENETICS (SOPH) has filed its Q2 2026 Form 6-K with the SEC, which includes unaudited interim financial statements and management discussion. This filing provides transparency to investors regarding the company's financial performance and operational trends. While analysts rate SOPH as a Buy with …

LifeMD (NASDAQ: LFMD) posts $15.96M loss but holds $25.1M cash and $30M credit line

LifeMD, Inc. reported a Q2 2026 net loss of $15.96 million from continuing operations, despite revenues of $47.3 million, a slight decrease from the prior year. The company maintains a strong liquidity position with $25.1 million in cash, no outstanding debt, and an undrawn …

Wondering what's happening in today's after-hours session?

This article provides an overview of the top gainers and losers in the US after-hours trading session on Wednesday, August 5, 2026. It highlights several companies, including MANGOCEUTICALS INC (MGRX) and CREATIVE MEDICAL TECHNOLOGY (CELZ) as top gainers, and YXT.COM GROUP HOLDING LTD (YXT) …

Earnings call transcript: Schrödinger beats Q2 2026 forecasts as shares rise

Schrödinger (SDGR) significantly exceeded Q2 2026 earnings and revenue forecasts, reporting a profit of $0.08 per share against an expected loss and revenue of $58.9 million, above estimates. The company saw a 27% increase in annual contract value, driven by strong demand for its …

GoodRx Holdings (NASDAQ: GDRX) pivots as Rx revenue falls 26%